vs

Side-by-side financial comparison of ADTRAN Holdings, Inc. (ADTN) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

MADRIGAL PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($321.1M vs $291.6M, roughly 1.1× ADTRAN Holdings, Inc.). ADTRAN Holdings, Inc. runs the higher net margin — -1.2% vs -18.2%, a 17.0% gap on every dollar of revenue. On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs 20.1%). ADTRAN Holdings, Inc. produced more free cash flow last quarter ($30.6M vs $-133.8M).

Adtran, Inc. is an American fiber networking and telecommunications company headquartered in Huntsville, Alabama. It is a vendor of both residential and enterprise networking equipment, along with administrative software for network management and deployment. Its customers include communications service providers, governments, enterprises and utilities.

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

ADTN vs MDGL — Head-to-Head

Bigger by revenue
MDGL
MDGL
1.1× larger
MDGL
$321.1M
$291.6M
ADTN
Growing faster (revenue YoY)
MDGL
MDGL
+190.7% gap
MDGL
210.8%
20.1%
ADTN
Higher net margin
ADTN
ADTN
17.0% more per $
ADTN
-1.2%
-18.2%
MDGL
More free cash flow
ADTN
ADTN
$164.4M more FCF
ADTN
$30.6M
$-133.8M
MDGL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADTN
ADTN
MDGL
MDGL
Revenue
$291.6M
$321.1M
Net Profit
$-3.6M
$-58.6M
Gross Margin
39.0%
Operating Margin
1.5%
-18.6%
Net Margin
-1.2%
-18.2%
Revenue YoY
20.1%
210.8%
Net Profit YoY
92.2%
1.4%
EPS (diluted)
$-0.02
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADTN
ADTN
MDGL
MDGL
Q4 25
$291.6M
$321.1M
Q3 25
$279.4M
$287.3M
Q2 25
$265.1M
$212.8M
Q1 25
$247.7M
$137.3M
Q4 24
$242.9M
$103.3M
Q3 24
$227.7M
$62.2M
Q2 24
$226.0M
Q1 24
$226.2M
$0
Net Profit
ADTN
ADTN
MDGL
MDGL
Q4 25
$-3.6M
$-58.6M
Q3 25
$-10.3M
$-114.2M
Q2 25
$-20.5M
$-42.3M
Q1 25
$-11.3M
$-73.2M
Q4 24
$-46.1M
$-59.4M
Q3 24
$-33.3M
$-107.0M
Q2 24
$-49.7M
Q1 24
$-330.8M
$-147.5M
Gross Margin
ADTN
ADTN
MDGL
MDGL
Q4 25
39.0%
Q3 25
38.3%
Q2 25
37.3%
Q1 25
38.4%
96.7%
Q4 24
36.9%
Q3 24
36.5%
Q2 24
36.0%
Q1 24
31.1%
Operating Margin
ADTN
ADTN
MDGL
MDGL
Q4 25
1.5%
-18.6%
Q3 25
-1.0%
-39.7%
Q2 25
-5.0%
-22.2%
Q1 25
-1.6%
-57.8%
Q4 24
-6.9%
-64.8%
Q3 24
-11.5%
-187.1%
Q2 24
-17.0%
Q1 24
-153.1%
Net Margin
ADTN
ADTN
MDGL
MDGL
Q4 25
-1.2%
-18.2%
Q3 25
-3.7%
-39.8%
Q2 25
-7.7%
-19.9%
Q1 25
-4.5%
-53.4%
Q4 24
-19.0%
-57.5%
Q3 24
-14.6%
-172.0%
Q2 24
-22.0%
Q1 24
-146.2%
EPS (diluted)
ADTN
ADTN
MDGL
MDGL
Q4 25
$-0.02
$-2.55
Q3 25
$-0.12
$-5.08
Q2 25
$-0.24
$-1.90
Q1 25
$-0.14
$-3.32
Q4 24
$-0.58
$-2.50
Q3 24
$-0.38
$-4.92
Q2 24
$-0.63
Q1 24
$-4.20
$-7.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADTN
ADTN
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$95.7M
$198.7M
Total DebtLower is stronger
$339.9M
Stockholders' EquityBook value
$145.8M
$602.7M
Total Assets
$1.2B
$1.3B
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADTN
ADTN
MDGL
MDGL
Q4 25
$95.7M
$198.7M
Q3 25
$93.7M
$295.7M
Q2 25
$106.3M
$186.2M
Q1 25
$101.3M
$183.6M
Q4 24
$76.0M
$100.0M
Q3 24
$88.5M
$232.7M
Q2 24
$111.2M
Q1 24
$106.8M
$622.5M
Total Debt
ADTN
ADTN
MDGL
MDGL
Q4 25
$339.9M
Q3 25
$339.8M
Q2 25
$118.4M
Q1 25
$118.0M
Q4 24
$117.6M
Q3 24
$117.1M
Q2 24
Q1 24
$116.1M
Stockholders' Equity
ADTN
ADTN
MDGL
MDGL
Q4 25
$145.8M
$602.7M
Q3 25
$141.6M
$625.7M
Q2 25
$169.6M
$696.0M
Q1 25
$138.9M
$710.6M
Q4 24
$127.0M
$754.4M
Q3 24
$205.6M
$777.2M
Q2 24
$213.6M
Q1 24
$260.8M
$850.8M
Total Assets
ADTN
ADTN
MDGL
MDGL
Q4 25
$1.2B
$1.3B
Q3 25
$1.2B
$1.4B
Q2 25
$1.2B
$1.0B
Q1 25
$1.2B
$996.6M
Q4 24
$1.2B
$1.0B
Q3 24
$1.3B
$1.1B
Q2 24
$1.3B
Q1 24
$1.3B
$1.1B
Debt / Equity
ADTN
ADTN
MDGL
MDGL
Q4 25
0.56×
Q3 25
0.54×
Q2 25
0.17×
Q1 25
0.17×
Q4 24
0.16×
Q3 24
0.15×
Q2 24
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADTN
ADTN
MDGL
MDGL
Operating Cash FlowLast quarter
$42.2M
$-133.5M
Free Cash FlowOCF − Capex
$30.6M
$-133.8M
FCF MarginFCF / Revenue
10.5%
-41.7%
Capex IntensityCapex / Revenue
4.0%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$98.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADTN
ADTN
MDGL
MDGL
Q4 25
$42.2M
$-133.5M
Q3 25
$12.2M
$79.8M
Q2 25
$32.2M
$-47.1M
Q1 25
$43.2M
$-88.9M
Q4 24
$2.4M
$-104.5M
Q3 24
$43.3M
$-67.0M
Q2 24
$19.9M
Q1 24
$37.9M
$-149.2M
Free Cash Flow
ADTN
ADTN
MDGL
MDGL
Q4 25
$30.6M
$-133.8M
Q3 25
$4.2M
$79.0M
Q2 25
$27.5M
Q1 25
$35.8M
Q4 24
$-895.0K
$-104.7M
Q3 24
$37.1M
$-67.8M
Q2 24
$8.4M
Q1 24
$24.4M
$-149.5M
FCF Margin
ADTN
ADTN
MDGL
MDGL
Q4 25
10.5%
-41.7%
Q3 25
1.5%
27.5%
Q2 25
10.4%
Q1 25
14.4%
Q4 24
-0.4%
-101.3%
Q3 24
16.3%
-109.0%
Q2 24
3.7%
Q1 24
10.8%
Capex Intensity
ADTN
ADTN
MDGL
MDGL
Q4 25
4.0%
0.1%
Q3 25
2.9%
0.3%
Q2 25
1.8%
0.0%
Q1 25
3.0%
0.0%
Q4 24
1.4%
0.2%
Q3 24
2.7%
1.3%
Q2 24
5.1%
Q1 24
6.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADTN
ADTN

Subscriber Solutions$96.2M33%
Optical Networking Solutions$81.8M28%
Access Aggregation Solutions$64.6M22%
Services And Support$48.9M17%

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons